MedTrace Logo

Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building

NCT03150238 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2017-05-12

No results posted yet for this study

Summary

The project will consist of a multicentre, prospective, observational study with a total duration of 24 months. Clinical, endoscopic and ultrasound data will be collected in a dedicated database (on IG-IBD Register), which will be used to identify potential clinical, endoscopic and ultrasound risk factors of re-operation. These data could be merged into a shared score, to stratify patients according to the risk of post-surgical re- operation and to define an optimal therapeutic management in the post- operative period. Approximately 220 adult patients, with a defined diagnosis of CD, who underwent a surgery for CD in the previous 6 months will be enrolled.

Conditions

  • Crohn Disease

Interventions

OTHER

observation of prognostic factors for relapse

The identification of the most relevant prognostic factors and the definition of their weight in predict the risk of re-intervention will be the basis for the definition of a combined score

Sponsors & Collaborators

  • Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)

    collaborator OTHER

  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Federica Furfaro, MD, phD · Istituto Clinico Humanitas

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-13
Primary Completion
2019-01-31
Completion
2019-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03150238 on ClinicalTrials.gov